Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Classificação em ações #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Preço da ação
$1.89
Última sincronização: 2022-12-16
Valor de mercado
$24.38M
Variação (1 dia)
8.62%
Variação (1 ano)
0.00%
País
US
Negociar Yumanity Therapeutics, Inc. (YMTX)

Categoria

Histórico de desdobramentos de ações de Yumanity Therapeutics, Inc. (YMTX)
As ações Yumanity Therapeutics, Inc. (símbolo: YMTX) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 19, 2026.
Uma ação YMTX comprada antes de Aug 19, 2026 equivaleria hoje a 0 ações YMTX.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH